press release Heajin Kim 9/17/25 press release Heajin Kim 9/17/25 Luxa Biotechnology Announces Publication in Cell Stem Cell Describing Positive Clinical Results for First-in-Human Clinical Trial for Dry AMD Therapy Read More press release Heajin Kim 5/12/25 press release Heajin Kim 5/12/25 Interview with Luxa Biotechnology Leadership: Promising Results of RPESC-RPE-4W for Dry AMD Read More press release Heajin Kim 4/29/25 press release Heajin Kim 4/29/25 Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting Read More press release Heajin Kim 3/9/25 press release Heajin Kim 3/9/25 Luxa Biotechnology Presents Clinical Data from First-in-Human Retinal Pigment Epithelium Cell Therapy Trial for Dry Age-Related Macular Degeneration at the 77th Annual Wills Eye Conference Read More press release Heajin Kim 3/6/25 press release Heajin Kim 3/6/25 Luxa's stem cell therapy for dry AMD shows early promise Read More Older Posts
press release Heajin Kim 9/17/25 press release Heajin Kim 9/17/25 Luxa Biotechnology Announces Publication in Cell Stem Cell Describing Positive Clinical Results for First-in-Human Clinical Trial for Dry AMD Therapy Read More
press release Heajin Kim 5/12/25 press release Heajin Kim 5/12/25 Interview with Luxa Biotechnology Leadership: Promising Results of RPESC-RPE-4W for Dry AMD Read More
press release Heajin Kim 4/29/25 press release Heajin Kim 4/29/25 Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting Read More
press release Heajin Kim 3/9/25 press release Heajin Kim 3/9/25 Luxa Biotechnology Presents Clinical Data from First-in-Human Retinal Pigment Epithelium Cell Therapy Trial for Dry Age-Related Macular Degeneration at the 77th Annual Wills Eye Conference Read More
press release Heajin Kim 3/6/25 press release Heajin Kim 3/6/25 Luxa's stem cell therapy for dry AMD shows early promise Read More
